The board of Lansen Pharmaceutical Holdings Limited has announced that due to other work commitments, with effect from 30 March, 2017, Mr. Stephen Burnau Hunt has resigned as the Chairman of the Board but remains as a Non-executive Director; and Mr. Tang Jun has resigned as a Non-executive Director. Mr. Stephen Burnau Hunt and Mr. Tang Jun confirmed that they have no disagreement with the Board and there is no matter relating to their resignation as the Chairman of the Board and a Non-executive Director respectively that needs to be brought to the attention of the shareholders of the company or the Stock Exchange. The company has announced that Mr. Wu Zhen Tao has been appointed as the Chairman of the Board and a Non-executive Director with effect from 30 March 2017. Mr. Wu Zhen Tao is the executive chairman of the board of directors and the chairman of the Executive Committee and Remuneration Committee of Cathay International Holdings Limited, and together with its subsidiaries, a company whose shares are listed on the London Stock Exchange, and a substantial shareholder of the company. Mr. Wu is the founder of the CIH Group, which has over 20 years' history of business and investment focused on the People's Republic of China (PRC). He is currently a director of a number of holding companies and subsidiaries of CIH.